Last reviewed · How we verify
Effect of drug on inflammatory biomarkers
Effect of drug on inflammatory biomarkers is a Small molecule drug developed by National Institute of Allergy and Infectious Diseases (NIAID). It is currently in Phase 1 development.
At a glance
| Generic name | Effect of drug on inflammatory biomarkers |
|---|---|
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Alanine aminotransferase increased
- Blood phosphorus decreased
- Blood sodium decreased
- Nausea
- Vomiting
- Aspartate aminotransferase increased
- Neutrophil count decreased
- Abdominal pain upper
- Diarrhoea
- Bacterial vaginosis
- Blood bilirubin increased
- Blood creatinine increased
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Effect of drug on inflammatory biomarkers CI brief — competitive landscape report
- Effect of drug on inflammatory biomarkers updates RSS · CI watch RSS
- National Institute of Allergy and Infectious Diseases (NIAID) portfolio CI
Frequently asked questions about Effect of drug on inflammatory biomarkers
What is Effect of drug on inflammatory biomarkers?
Effect of drug on inflammatory biomarkers is a Small molecule drug developed by National Institute of Allergy and Infectious Diseases (NIAID).
Who makes Effect of drug on inflammatory biomarkers?
Effect of drug on inflammatory biomarkers is developed by National Institute of Allergy and Infectious Diseases (NIAID) (see full National Institute of Allergy and Infectious Diseases (NIAID) pipeline at /company/national-institute-of-allergy-and-infectious-diseases-niaid).
What development phase is Effect of drug on inflammatory biomarkers in?
Effect of drug on inflammatory biomarkers is in Phase 1.
What are the side effects of Effect of drug on inflammatory biomarkers?
Common side effects of Effect of drug on inflammatory biomarkers include Alanine aminotransferase increased, Blood phosphorus decreased, Blood sodium decreased, Nausea, Vomiting, Aspartate aminotransferase increased.